Home
|
About
|
Quick Start
|
FAQ
Beta Version 0.1
DHARA is an online index of articles on Ayurveda published in research journals worldwide.
Users Online:
2304
Unfiltered
Classified Search
Enter Keyword Below :
Advanced
Journal of Research in Ayurvedic Sciences
2019
April - June
;
3
(2)
:74-83
Traditional Ayurveda Medicines for the Management of Amlapitta (Functional Dyspepsia): A Study Protocol for a Prospective, Single-arm, Open-label Clinical Trial
Babita Yadav (1)
,
Babita Yadav (1)
,
Bidhan Mahajon (2)
,
Bidhan Mahajon (2)
,
Neha Dubey (3)
,
Neha Dubey (3)
,
Ashok Kumar Panda (4)
,
Ashok Kumar Panda (4)
,
Bhogavalli Chandrasekhara Rao (2)
,
Bhogavalli Chandrasekhara Rao (2)
,
Richa Singhal (2)
,
Richa Singhal (2)
,
Narayanam Srikanth (2)
,
Narayanam Srikanth (2)
1. 7Central Council for Research in Ayurvedic Sciences, New Delhi, India 2. Central Council for Research in Ayurvedic Sciences, New Delhi, India 3. Central Council for Research in Ayurvedic Sciences, New Delhi, India 4. Central Ayurveda Research Institute for Hepatobilliary Disorders, Bhubaneswar, Odisha, India
Abstract
Background: Amlapitta (functional dyspepsia, FD) is experienced as a heterogeneous group of upper abdominal symptoms characterized by upper abdominal colic or discomfort which may also comprise heartburn, bloating, regurgitation, early satiety, anorexia, postprandial fullness, belching, and nausea. Traditional Ayurveda medicines are frequently practiced for FD since long; however, available scientific proof relating to their competence and mechanism of actions are insubstantial. In this article, we report a protocol of a prospective, single-arm, open-label, multicenter clinical study by means of classical Ayurveda formulation to examine the effectiveness, mechanism, and safety of the patients diagnosed with Amlapitta (FD). Materials and methods: Present protocol is a single-arm, open-label multicenter clinical study to find the safety and efficacy of classical Ayurveda formulations Narikela Lavana and Amalakyadi Churna in the management of Amlapitta. A total of 110 patients with Amlapitta will be selected based on the inclusion and exclusion criteria. All the patients will be treated orally; with traditional Ayurveda medicine, i.e., powder Narikela Lavana 2 g, twice daily, before food; and Amalakyadi Churna 3 g, twice daily, after food. The entire participant will undergo 12-week treatment and 2-week follow-up. A total of seven visits will be scheduled for each of the participants, i.e., each one in week 0, 2, 4, 6, 8, 10, and 12. The primary outcomes include changes in FD symptoms in dyspepsia questionnaire; changes in symptoms of Amlapitta disease in Amlapitta symptom rating scale (ASRS) along with satisfactory therapeutic response. The secondary outcomes include disease relapse rate after successful treatment; assessment of quality of life in the participants of FD by the World Health Organization Quality of Life (WHO-QOL) scale; and psychological assessment by Beck’s depression inventory scoring scale. Therapeutic mechanism outcomes, safety outcomes, and end-point outcomes will also be assessed. Discussion: Present protocol has been designed with expected better clinical outcome and safety profile in dyspepsia patients in addition to reduce relapse rate of disease during posttreatment period. If found effective, the selected drug will be listed in terms of better efficacy, safety, and cost-effective treatment of Amlapitta. The selected drug may lead to a step ahead of better understanding and management of other gastrointestinal disorders. Trial registration: Trial has been registered REF/2019/07/027369. The registration number for this trial is CTRI/2019/09/021133. Keywords: Amlapitta, Ayurveda medicine, Clinical trials, Functional dyspepsia, Treatment.
DHARA ID:
D059622
Link To Full Paper
Replica Louis vuitton Belts
Replica Louis vuitton Handbags
Replica Louis vuitton Backpack
Replica Louis vuitton Capucines Bags
Imitazioni Louis vuitton Borse
Imitazioni Louis vuitton Cinture
Imitazioni Louis vuitton Occhiali
Replica Louis vuitton Geldb?rsen
Replica Louis vuitton Gürtel
Replica Louis vuitton Schmuck
Replica Louis vuitton Schal
Imitation Louis vuitton Bijoux
Imitation Louis vuitton Ceinture
Imitation Louis vuitton Chaussures
Imitation Louis vuitton Foulard
namaak Louis vuitton Gordels
namaak Louis vuitton Handtassen
namaak Louis vuitton Portemonnees
namaak Louis vuitton Schoenen
Replica Louis vuitton Bolsos
Replica Louis vuitton Billeteras
Replica Louis vuitton Cinturones
Dior Replica
Hermès Replica
Yves Saint Laurent Replica
Goyard Replica
Imitation Louis Vuitton
Imitation Hermès
Imitation Dior
Imitation Yves Saint Laurent
Imitazioni Bottega Veneta Borse
Imitazioni Delvaux Borse
Imitazioni Goyard Borse
Replica Taschen
Replica Louis Vuitton
Replica Hermès
Replica Dior
Replica Bottega Veneta tassen
Replica Chloé tassen
Replica Delvaux tassen
Replica Goyard tassen
imitacion Louis Vuitton
imitacion Louis Vuitton
imitacion Hermès
imitacion Dior
Replica Miu Miu
Replica Prada
Replica Yves Saint Laurent
Replica Chanel
Replica Gucci
Replica Hermès
Replica Miu Miu
Réplique Chanel
Réplique Hermès
Réplique Miu Miu
Imitazioni Chanel
Imitazioni Hermès
Imitazioni Miu Miu
imitacion Bolso Yves Saint Laurent
imitacion Hermes
imitacion Chanel
imitacion Gucci
Gucci Replica
Hermes Replica
Copyright
|
Disclaimer
|
Feedback
|
Updates
|
Contact
Developed and maintained by AVP Research Foundation (Formerly AVT Institute for Advanced Research), 136/137, Trichy Road, Ramanathapuram, Coimbatore - 641045, Tamil Nadu, India
Funded by Central Council for Research in Ayurvedic Sciences, Dept. of AYUSH, Ministry of Health and Family Welfare, Government of India, New Delhi